ARCHIVE

• SEMI-ANNUAL BUSINES RESULTS
  December 1, 2003

• Teijin: Sales Up, but Operating Profits Hit by R&D Costs
  December 1, 2003

• Hearings on Late-night, Early-morning Drug Sales Held
  December 1, 2003

• Sawai: Favorable GE Market Drives Strong Growth in Sales, Profits
  December 1, 2003

• OTC NEWS IN BRIEF
  December 1, 2003

• Kuraya Sanseido: Sales, Net Profits Up Slightly
  December 1, 2003

• PRESS SEMINAR
  December 1, 2003

• Kissei: Sales Increase 1.3%, Profits Up 281.2%
  December 1, 2003

• WORLD NEWS IN BRIEF
  December 1, 2003

• Nippon Shinyaku: Sales Up Slightly, Profits Hit by Higher Costs
  December 1, 2003

• Rewards for Innovativeness in New Drugs to Be Needed: Mr Ager of EFPIA
  December 1, 2003

• Kaken: Ordinary Profits Down, but R&D Tax Credit Boosts Net Profits
  December 1, 2003

• ICH-6 in Osaka Focuses on New Horizons and Future Challenges (1)
  December 1, 2003

• Meiji Seika: Drug Division Sales Up 6.5% to \49.5 Bil.
  December 1, 2003

• Chuikyo Discusses NPA Recommendation, Consumer Prices
  December 1, 2003

• Suzuken: Consolidated Sales Up 15% to \558.1 Bil.
  December 1, 2003

• REGULATORY NEWS IN BRIEF
  December 1, 2003

• Toho: Sales Up 17.4%, Net Profits Up 44.9%
  December 1, 2003

• CORPORATE ROUNDUP NEWS IN BRIEF
  December 1, 2003

• Takeover of Nikken Chemicals to Make Kowa Strengthen Marketing, R&D: President Miwa
  December 1, 2003

ページ

• « 先頭
• ‹ Prev
• …
• 560
• 561
• 562
• 563
• 564
• 565
• 566
• 567
• 568
• …
• Next ›
• 最終 »